CYTOVATION ASA

Operating

a) Forskning, utvikling og industrialisering innen genterapi og kreftbehanling. b) Kommersialisere resultater av forskning og utvikling på dette området. Drive konsulentvirksomhet eller forestå underleveranser relatert til formål som beskrevet i pkt. a og b. Selskapets formål kan også oppnås ved å erverve eiendeler i andre selskaper og delta i annen virksomhet.

Forskning, utvikling og industrialisering innen genterapi og kreftbehandling. Kommersialisering av resultater av forskning og utvikling på dette området.

Organization

CEO: LP
Lars Prestegarden1979
Chairman of the board: SC
Stein Christian Mohn1973
Years since formation: 25 years; since Sep 6, 2001
Type: Public limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 1,868,771; 1 share class
Total number of shareholders: 58; 46 companies, 12 persons

Financials

Annual total result 2025: -46,680,385; NOK

Last update: Jul 29, 2026

Management

Management / administration

Name	Role	Shares
LP Lars Prestegarden 1979	Managing Director/CEO	-

Board

Name	Role	Shares
SC Stein Christian Mohn 1973	Chairman	-
OH Olav Hellebø 1965	Board Member	-
EA Ellen Alla Lubman 1975	Board Member	-
MW Martin William Dewhurst 1963	Board Member	-
KS Katherine Skye Mellis 1992	Board Member	-

Others

Name	Role	Shares
P PRICEWATERHOUSECOOPERS AS	Auditor	-
V VIEW GROUP AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
MA Myrlid Aasen Kjetil 1975	-	14.48 % directly 0.05 % indirectly 14.43 %
LN Langeland Nilsen Kjeld-Håkon 1972	-	3.75 % indirectly
KS Krage Svensen Carina 1975	-	1.93 % indirectly
EA Eivindssøn Astrup Nikolai 1978	-	1.62 % indirectly
KS Krage Svensen Thomas 1973	-	1.53 % indirectly
PL Prestegarden Lars 1979	-	1.29 % indirectly
EL Eystein Lønning Per 1953	-	1.28 % directly
BR Bjerkvig Rolf 1953	-	1.28 % directly
EA Eivindssøn Astrup Henning 1982	-	1.25 % indirectly

Last update: May 13, 2025

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
S SANDWATER FUND I AS	Ordinary shares	388,009	20.76 %
C CANICA AS	Ordinary shares	237,157	12.69 %
M MYRLID AS	Ordinary shares	200,000	10.7 %
J JANDERSEN KAPITAL AS	Ordinary shares	139,310	7.45 %
I INNOVEST AS	Ordinary shares	129,886	6.95 %
C CYTOVATION ASA	Ordinary shares	106,357	5.69 %
C CYTO INVEST AS	Ordinary shares	83,746	4.48 %
P PACTUM VEKST AS	Ordinary shares	80,799	4.32 %
B BERGENSKANTEN AS	Ordinary shares	58,764	3.14 %
I INNOVEST AS	Ordinary shares	47,700	2.55 %
M MNG HOLDING BERGEN AS	Ordinary shares	37,280	1.99 %
B BAGGINS VENTURE AS	Ordinary shares	33,856	1.81 %
V VICAMA AS	Ordinary shares	30,000	1.61 %
H HEALTH CARE INVEST AS	Ordinary shares	26,095	1.4 %
L LP-INVEST AS	Ordinary shares	24,052	1.29 %
EL Eystein Lønning Per 1953	Ordinary shares	23,994	1.28 %
BR Bjerkvig Rolf 1953	Ordinary shares	23,900	1.28 %
M MARIUS MASKE AS	Ordinary shares	23,000	1.23 %
Z ZINOBER INVEST AS	Ordinary shares	15,000	0.8 %
S STORM NORGE AS	Ordinary shares	14,259	0.76 %
K KANNIKVEGEN INVEST AS	Ordinary shares	12,500	0.67 %
D DRAKE STREET AS	Ordinary shares	11,913	0.64 %
M MASIMA AS	Ordinary shares	10,965	0.59 %
C CANICA AS	Ordinary shares	10,680	0.57 %
P P2XAL AS	Ordinary shares	10,000	0.54 %
C CYTOVATION ASA	Ordinary shares	6,995	0.37 %
L LEOPOLD INVEST AS	Ordinary shares	5,966	0.32 %
M MNG HOLDING BERGEN AS	Ordinary shares	5,612	0.3 %
N NIAN AS	Ordinary shares	5,340	0.29 %
I INVESTEEN AS	Ordinary shares	5,000	0.27 %
S SAWTOOTH AS	Ordinary shares	5,000	0.27 %
P PACTUM VEKST AS	Ordinary shares	3,631	0.19 %
C CK CAPITAL AS	Ordinary shares	3,415	0.18 %
IA Inge Arnevig Kjell 1964	Ordinary shares	3,189	0.17 %
CM Christian Mohn Stein 1973	Ordinary shares	2,500	0.13 %
G GOM INVEST AS	Ordinary shares	2,094	0.11 %
K KIRKESTUEN INVEST AS	Ordinary shares	1,812	0.1 %
L LOMME AS	Ordinary shares	1,611	0.09 %
AR Andreas Reigstad Jens 1953	Ordinary shares	1,500	0.08 %
H HEALTH CARE INVEST AS	Ordinary shares	1,323	0.07 %
G GEIR GULLIKSEN INVEST AS	Ordinary shares	1,319	0.07 %
Z ZINOBER INVEST AS	Ordinary shares	1,189	0.06 %
P PURE FUTURE AS	Ordinary shares	1,185	0.06 %
MA Myrlid Aasen Kjetil 1975	Ordinary shares	1,000	0.05 %
S STORM NORGE AS	Ordinary shares	641	0.03 %
GØ Grimnes Øven 1945	Ordinary shares	500	0.03 %
N NIAN AS	Ordinary shares	464	0.02 %
K KHN HOLDING AS	Ordinary shares	400	0.02 %
M MKV CAP AS	Ordinary shares	210	< 0.01 %
P PLAN ELBRUS AS	Ordinary shares	171	< 0.01 %
A ASTON AS	Ordinary shares	163	< 0.01 %
SØ Svanevik Ørjan 1966	Ordinary shares	107	< 0.01 %
KS Kristian Stornes Ågotnes Ole 1978	Ordinary shares	53	< 0.01 %
G GOM INVEST AS	Ordinary shares	26	< 0.01 %
S SANDVANN AS	Ordinary shares	22	< 0.01 %
BK Bø Kronstad Christian 1990	Ordinary shares	20	< 0.01 %
TO Tveit Ola 1985	Ordinary shares	10	< 0.01 %
HH Heier Hansen-Tangen Charlotte 1990	Ordinary shares	9	< 0.01 %

Shares owned by the CYTOVATION ASA

Name	Share class	Total number of shares	Share
C CYTOVATION ASA	Ordinary shares	106,357	5.69 %

Last update: Sep 25, 2026

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	0	0	0	0	0
Annual Total Result	-46,680,385	-62,895,103	-81,511,885	-122,909,417	-34,365,250
Total assets	0	15,779,127	78,156,381	83,917,564	107,451,738
Total liabilities	0	109,110,850	108,593,001	32,842,299	20,341,570
Total equity	0	-93,331,724	-30,436,620	51,075,265	87,110,169

P&L

Year	2025	2024	2023	2022	2021
Total operating income	0	0	0	0	0
Total operating costs	46,164,656	54,807,862	77,245,362	122,064,133	33,705,659
Operating result	-46,164,656	-54,807,862	-77,245,362	-122,064,133	-33,705,659
Financial income/costs	-515,730	-8,087,242	-4,266,523	-845,284	-659,591
Profit before tax	-46,680,385	-62,895,103	-81,511,885	-122,909,417	-34,365,250
Total tax & extraordinary income/cost	0	0	0	0	0
Annual Total Result	-46,680,385	-62,895,103	-81,511,885	-122,909,417	-34,365,250

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	242,595	274,258	94,163	31,663
Total current assets	15,536,531	77,882,122	83,823,401	107,420,075
Total assets	15,779,127	78,156,381	83,917,564	107,451,738
Short term debt	8,872,317	17,467,062	21,936,315	9,435,586
Long term debt	100,238,533	91,125,939	10,905,984	10,905,984
Total liabilities	109,110,850	108,593,001	32,842,299	20,341,570
Contributed capital	1,212,085	1,212,085	51,075,265	99,107,132
Retained earnings	-94,543,809	-31,648,705	0	-11,996,963
Total equity	-93,331,724	-30,436,620	51,075,265	87,110,169
Total equity and liabilities	15,779,127	78,156,381	83,917,564	107,451,738

Classification

21st company classification

BETA

Small company

Type of organization

Public limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

Standard industrial classification

CYTOVATION ASA983 644 600

CYTOVATION ASA

Organization

Ownership

Financials

Management

Management / administration

Board

Others

Top 10 individual shareholders

Ownership

Company shareholders

Shares owned by the CYTOVATION ASA

Financials

Summary

P&L

Balance overview

Classification